Germany is reassessing AstraZeneca Plc’s Covid-19 vaccine after the capital Berlin suspended its use for people under the age of 60, citing new data on potentially dangerous side effects.
Read More
Germany is reassessing AstraZeneca Plc’s Covid-19 vaccine after the capital Berlin suspended its use for people under the age of 60, citing new data on potentially dangerous side effects.
Read More
Sign Up For Updates & Newsletters
